These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 17310052)

  • 41. Thromboprophylaxis with low molecular weight heparin versus unfractionated heparin in intensive care patients: a systematic review with meta-analysis and trial sequential analysis.
    Beitland S; Sandven I; Kjærvik LK; Sandset PM; Sunde K; Eken T
    Intensive Care Med; 2015 Jul; 41(7):1209-19. PubMed ID: 25971389
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Economic and utilization outcomes associated with choice of treatment for venous thromboembolism in hospitalized patients.
    Knight KK; Wong J; Hauch O; Wygant G; Aguilar D; Ofman JJ
    Value Health; 2005; 8(3):191-200. PubMed ID: 15877591
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer.
    Lee AY; Levine MN; Baker RI; Bowden C; Kakkar AK; Prins M; Rickles FR; Julian JA; Haley S; Kovacs MJ; Gent M;
    N Engl J Med; 2003 Jul; 349(2):146-53. PubMed ID: 12853587
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients.
    Leizorovicz A; Cohen AT; Turpie AG; Olsson CG; Vaitkus PT; Goldhaber SZ;
    Circulation; 2004 Aug; 110(7):874-9. PubMed ID: 15289368
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Thromboprophylaxis for trauma patients.
    Barrera LM; Perel P; Ker K; Cirocchi R; Farinella E; Morales Uribe CH
    Cochrane Database Syst Rev; 2013 Mar; (3):CD008303. PubMed ID: 23543562
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Venous thromboembolism in the ICU and reversal of bleeding on anticoagulants.
    DeLoughery TG
    Crit Care Clin; 2005 Jul; 21(3):497-512. PubMed ID: 15992670
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Low molecular weight heparin versus other anti-thrombotic agents for prevention of venous thromboembolic events after total hip or total knee replacement surgery: a systematic review and meta-analysis.
    Lu X; Lin J
    BMC Musculoskelet Disord; 2018 Sep; 19(1):322. PubMed ID: 30193575
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Prevention of venous thromboembolism in internal medicine and neurology].
    Malý J; Dulícek P; Penka M; Malý R; Gumulec J
    Vnitr Lek; 2006 Mar; 52 Suppl 1():63-7. PubMed ID: 16637452
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Meta-analysis of heparin therapy for preventing venous thromboembolism in acute spinal cord injury.
    Liu Y; Xu H; Liu F; Lv Z; Kan S; Ning G; Feng S
    Int J Surg; 2017 Jul; 43():94-100. PubMed ID: 28579397
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer: A Randomized Clinical Trial.
    Lee AYY; Kamphuisen PW; Meyer G; Bauersachs R; Janas MS; Jarner MF; Khorana AA;
    JAMA; 2015 Aug; 314(7):677-686. PubMed ID: 26284719
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anticoagulant prophylaxis for hospitalized medical patients.
    Lederle FA; MacDonald R; Wilt TJ
    Ann Intern Med; 2007 Oct; 147(7):523-4; author reply 524. PubMed ID: 17909221
    [No Abstract]   [Full Text] [Related]  

  • 52. Efficacy of unfractionated heparin for thromboembolism prophylaxis in medical patients.
    Yalamanchili K; Sukhija R; Sinha N; Aronow WS; Maguire GP; Lehrman SG
    Am J Ther; 2005; 12(4):293-9. PubMed ID: 16041191
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thromboprophylaxis after Knee Arthroscopy and Lower-Leg Casting.
    van Adrichem RA; Nemeth B; Algra A; le Cessie S; Rosendaal FR; Schipper IB; Nelissen RGHH; Cannegieter SC;
    N Engl J Med; 2017 Feb; 376(6):515-525. PubMed ID: 27959702
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Prevention of pulmonary embolism].
    Minar E
    Acta Med Austriaca; 1992; 19(1):25-34. PubMed ID: 1316706
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Deep venous thrombosis and pulmonary embolism. Part 2--Prevention of recurrences: warfarin or low-molecular-weight heparin for at least 3 months.
    Prescrire Int; 2013 May; 22(138):129-33. PubMed ID: 23819181
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rationale and design of a clinical trial of a low-molecular-weight heparin in preventing clinically important venous thromboembolism in medical patients: the prospective evaluation of dalteparin efficacy for prevention of venous thromboembolism in immobilized patients trial (the PREVENT study).
    Vaitkus PT; Leizorovicz A; Goldhaber SZ;
    Vasc Med; 2002; 7(4):269-73. PubMed ID: 12710842
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Management of venous thromboembolism: a systematic review for a practice guideline.
    Segal JB; Streiff MB; Hofmann LV; Thornton K; Bass EB
    Ann Intern Med; 2007 Feb; 146(3):211-22. PubMed ID: 17261856
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis.
    Breddin HK; Hach-Wunderle V; Nakov R; Kakkar VV;
    N Engl J Med; 2001 Mar; 344(9):626-31. PubMed ID: 11228276
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Venous thromboembolism: deep venous thrombosis and pulmonary embolism in a neurosurgical population.
    Khaldi A; Helo N; Schneck MJ; Origitano TC
    J Neurosurg; 2011 Jan; 114(1):40-6. PubMed ID: 20815694
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment and prophylaxis of venous thromboembolism during pregnancy.
    Bates SM
    Thromb Res; 2002 Nov; 108(2-3):97-106. PubMed ID: 12590944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.